The Association between Nonalcoholic Fatty Pancreas Disease and Diabetes

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Ou, Horng Yih ^a   Wang, Chih Yuan ^b   Yang, Yi Ching ^a   Chen, Ming Fong ^b   Chang, Chih Jen ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ARTICLE; CARDIOMETABOLIC RISK; CHINESE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY PANCREAS DISEASE; OBESITY; PANCREAS DISEASE; RETROSPECTIVE STUDY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PANCREATIC DISEASES; PREDIABETIC STATE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84877016638     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062561     Document Type: Article

References (54)

1. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, et al. (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377: 557-567.
2. Goossens GH, (2008) The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 94: 206-218.
3. Despres JP, Lemieux I, (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-887.
4. Coutinho T, Goel K, Correa de Sa D, Kragelund C, Kanaya AM, et al. (2011) Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol 57: 1877-1886.
5. Lee CM, Huxley RR, Wildman RP, Woodward M, (2008) Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol 61: 646-653.
6. Seppala-Lindroos A, Vehkavaara S, Hakkinen A-M, Goto T, Westerbacka J, et al. (2002) Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men. J Clin Endocrinol Metab 87: 3023-3028.
7. Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H, (2007) Liver Fat in the Metabolic Syndrome. J Clin Endocrinol Metab 92: 3490-3497.
8. Targher G, Bertolini L, Poli F, Rodella S, Scala L, et al. (2005) Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54: 3541-3546.
9. Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, et al. (2004) Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese, Nondiabetic Adults. Arch Intern Med 164: 2169-2175.
10. Mathur A, Marine M, Lu D, Swartz-Basile DA, Saxena R, et al. (2007) Nonalcoholic fatty pancreas disease. HPB (Oxford) 9: 312-318.
11. Smits M, van Geenen E, (2011) The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 8: 169-177.
12. Pitt H, (2007) Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford) 9: 92-97.
13. Mathur A, Zyromski N, Pitt H, Al-Azzawi H, Walker J, et al. (2009) Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg 208: 989.
14. Mathur A, Pitt HA, Marine M, Saxena R, Schmidt CM, et al. (2007) Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg 246: 1058-1064.
15. Gaujoux S, Cortes A, Couvelard A, Noullet S, Clavel L, et al. (2010) Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery 148: 15-23.
16. Zhang X, Cui Y, Fang L, Li F, (2008) Chronic high-fat diets induce oxide injuries and fibrogenesis of pancreatic cells in rats. Pancreas 37: e31-38.
17. Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA, (2010) A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet. J Clin Biochem Nutr 46: 212-223.
18. Fernandes-Santos C, Evangelista Carneiro R, de Souza Mendonca L, Barbosa Aguila M, Mandarim-de-Lacerda CA, (2009) Rosiglitazone aggravates nonalcoholic Fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet. Pancreas 38: e80-86.
19. Sepe PS, Ohri A, Sanaka S, Berzin TM, Sekhon S, et al. (2011) A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc 73: 987-993.
20. Lee JS, Kim SH, Jun DW, Han JH, Jang EC, et al. (2009) Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 15: 1869-1875.
21. Hannukainen JC, Borra R, Linderborg K, Kallio H, Kiss J, et al. (2011) Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activity. J Hepatol 54: 545-552.
22. van Geenen EJ, Smits MM, Schreuder TC, van der Peet DL, Bloemena E, et al. (2010) Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas 39: 1185-1190.
23. Al-Haddad M, Khashab M, Zyromski N, Pungpapong S, Wallace MB, et al. (2009) Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas 38: 672-675.
24. Tushuizen ME, Bunck MC, Pouwels PJ, Bontemps S, van Waesberghe JH, et al. (2007) Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 30: 2916-2921.
25. Heni M, Machann J, Staiger H, Schwenzer NF, Peter A, et al. (2010) Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 26: 200-205.
26. van der Zijl NJ, Goossens GH, Moors CC, van Raalte DH, Muskiet MH, et al. (2011) Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on beta-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab 96: 459-467.
27. American Diabetes Association, (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33Suppl 1: S62-69.
28. Schwenzer N, Machann J, Martirosian P, Stefan N, Schraml C, et al. (2008) Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol 43: 330-337.
29. Rossi A, Fantin F, Zamboni G, Mazzali G, Rinaldi C, et al. (2011) Predictors of ectopic fat accumulation in liver and pancreas in obese men and women. Obesity (Silver Spring) 19: 1747-1754.
30. Lonardo A, Carani C, Carulli N, Loria P, (2006) 'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. J Hepatol 44: 1196-1207.
31. Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, et al. (2004) Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145: 5087-5096.
32. Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, et al. (1998) Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273: 32487-32490.
33. van Raalte DH, van der Zijl NJ, Diamant M, (2010) Pancreatic steatosis in humans: cause or marker of lipotoxicity? Curr Opin Clin Nutr Metab Care 13: 478-485.
34. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, et al. (1994) Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A 91: 10878-10882.
35. Le KA, Ventura EE, Fisher JQ, Davis JN, Weigensberg MJ, et al. (2011) Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care 34: 485-490.
36. Kahn SE, (2001) Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86: 4047-4058.
37. Rasmussen BB, Holmback UC, Volpi E, Morio-Liondore B, Paddon-Jones D, et al. (2002) Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. J Clin Invest 110: 1687-1693.
38. Kotronen A, Yki-Jarvinen H, (2008) Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 28: 27-38.
39. Vanni E, Bugianesi E, Kotronen A, De Minicis S, Yki-Järvinen H, et al. (2010) From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 42: 320-330.
40. Suzuki A, Angulo P, Lymp J, St Sauver J, Muto A, et al. (2005) Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology 41: 64-71.
41. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, et al. (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51: 1889-1895.
42. Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, et al. (2005) Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. Diabetes Care 28: 1757-1762.
43. Balkau B, Lange C, Vol S, Fumeron F, Bonnet F, (2010) Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol 10: 56.
44. Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, et al. (2009) Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care 32: 741-750.
45. Adams LA, Sanderson S, Lindor KD, Angulo P, (2005) The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 42: 132-138.
46. Porepa L, Ray JG, Sanchez-Romeu P, Booth GL, (2010) Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ 182: E526-531.
47. Loria P, Lonardo A, Anania F, (2013) Liver and diabetes. A vicious circle. Hepatol Res 43: 51-64.
48. Ruckert IM, Heier M, Rathmann W, Baumeister SE, Doring A, et al. (2011) Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study. PLoS One 6: e22932.
49. Stefan N, Kantartzis K, Haring HU, (2008) Causes and metabolic consequences of Fatty liver. Endocr Rev 29: 939-960.
50. Utzschneider KM, Kahn SE, (2006) Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 91: 4753-4761.
51. Tseng CH, Chong CK, Chan TT, Bai CH, You SL, et al. (2010) Optimal anthropometric factor cutoffs for hyperglycemia, hypertension and dyslipidemia for the Taiwanese population. Atherosclerosis 210: 585-589.
52. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, et al. (2008) The metabolic syndrome. Endocr Rev 29: 777-822.
53. Alzaid A, Aideyan O, Nawaz S, (1993) The size of the pancreas in diabetes mellitus. Diabet Med 10: 759-763.
54. Marks WM, Filly RA, Callen PW, (1980) Ultrasonic evaluation of normal pancreatic echogenicity and its relationship to fat deposition. Radiology 137: 475-479.